About: Saratoga Opthalmology

Posts by Saratoga Opthalmology:

Study reveals possible link between tuberculosis and Behçet disease

This study evaluates the associations between tuberculosis (TB) infection and risk of Behçet disease. Source: AAO

Posted on: Jun 15 2021
By: Saratoga Opthalmology
Leave a reponse

Black patients may experience less vision improvement after bevacizumab for DME

This retrospective cohort analysis examined the impact of race and ethnicity on the efficacy of intravitreal bevacizumab for diabetic macular edema (DME). Source: AAO

Posted on: Jun 11 2021
By: Saratoga Opthalmology
Leave a reponse

Study details ocular complications of drug-induced Stevens-Johnson syndrome

This study compared the severity of chronic ocular complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) triggered by lamotrigine (LT) and trimethoprim-sulfamethoxazole (TS). Source: AAO

Posted on: Jun 9 2021
By: Saratoga Opthalmology
Leave a reponse

Aflibercept may reduce risk of PDR and DME in patients with severe NPDR

Investigators evaluated the efficacy of intravitreous aflibercept injections in mitigating complications in eyes with moderate to severe nonproliferative diabetic retinopathy (NPDR). Source: AAO

Posted on: Jun 4 2021
By: Saratoga Opthalmology
Leave a reponse

Improving early access to neuro-ophthalmologists will reduce patient harm

This study assessed the diagnostic error of neuro-ophthalmic conditions by referring providers and how it impacts patients. Source: AAO

Posted on: Jun 3 2021
By: Saratoga Opthalmology
Leave a reponse

Delayed IOL implantation ensures better refractive outcomes for infantile cataract

The authors report outcomes of secondary IOL implantation in the Infant Aphakia Treatment Study (IATS). Source: AAO

Posted on: May 28 2021
By: Saratoga Opthalmology
Leave a reponse

Cardiovascular disease is a significant risk factor for glaucoma

This prospective, longitudinal study assessed the association between cardiovascular disease and glaucoma. Source: AAO

Posted on: May 28 2021
By: Saratoga Opthalmology
Leave a reponse

IRIS Registry study reveals decline in bevacizumab use

This IRIS Registry study assessed use of bevacizumab among patients with Medicare fee-for-service health insurance between 2013 and 2019. Source: AAO

Posted on: May 25 2021
By: Saratoga Opthalmology
Leave a reponse

Overminus spectacles for intermittent exotropia linked to myopic shift

This is the first large-scale, randomized clinical trial assessing overminus spectacle therapy for treatment of intermittent exotropia (IXT). Source: AAO

Posted on: May 19 2021
By: Saratoga Opthalmology
Leave a reponse

Two cases of corneal transplant rejection after COVID-19 vaccination

This study describes 2 cases of corneal allograft rejection after receiving the COVID-19 vaccine (BNT162b2; Pfizer-BioNTech). Prior to receiving the vaccine, each patient underwent Descemet’s membrane endothelial keratoplasty (DMEK) for Fuchs endothelial corneal dystrophy (FECD). Source: AAO